The Next Generation Sequencing (NGS) Market is Expected to Surpass US$ 30 Billion by the End of Year 2025, with Double Digit CAGR during 2019-2025

DUBLIN--()--The "Next Generation Sequencing (NGS) Market, Global Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform, Consumable" report has been added to's offering.


Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of the year 2025 with double digit CAGR during 2019-2025

Next-Generation Sequencing has revolutionized biological study, with its ultra-high throughput, speed, and scalability; it has enabled professionals to perform a wide variety of applications and study biological systems at a level which have never been possible before.

The NGS technology is also referred to as High Throughput Sequencing. This technique minimizes the necessity for fragment-cloning methods used in Sanger sequencing of genomes. The NGS offers rapid speed, low cost, high accuracy, and accurate result even with the low sample input. The use of NGS in clinical diagnostic is one of the major factors for the future growth of NGS.

Next Generation Sequencing has the possibility to accelerate the early finding of the ailments and the recognition of pharmacogenetics markers to customize its treatments. Today, in the field of medical science, a lot of various technological advancements are going at a rapid pace and that has led to the development of a specific medicine. As a result, the development of custom made medicine has opened enormous opportunities for the application of next-generation sequencing, which could help the NGS market to grow significantly over the forecast period.

In addition; some of the major factors responsible for the growth of Next Generation Sequencing are increasing NGS application in the biological study due to its efficient advantage over traditional technologies and growing demand from the drug discovery industry. Additionally, ethical concerns associated with the whole-genome sequencing along with the lack of awareness among people are some of the factors which are expected to restrain the market growth during the forecast period.

Oncology Test Market is the largest among Clinical Next Generation Sequencing Market

In this report, we have defined the next-generation sequencing test market by clinical application. NGS test market is categorized into 6 parts; NGS Test Market by Reproductive Health, NGS Test Market by Rare Disease, NGS Test Market by Oncology, NGS Test Market by Metabolic, NGS Test Market by Cardiovascular and Others NGS Test Market.

Target Re-Sequencing and Whole Exome sequencing is dominating the Clinical Next Generation Sequencing Market

In this report, we have done a complete assessment of different next-generation sequencing technique. Here, we have categorized clinical next-generation sequencing market by type of test into six parts; Targeted Re-sequencing (TPS/WES), Transcriptome (RNA- Sequencing), Whole Genome Sequencing, ChIP- Sequencing, De Novo Sequencing (Novel Organisms) and Methyl-Sequencing.

Next Generation Sequencing Market Trends by Platform

There are several platforms designed for next-generation sequencing for the period of time by top key players. In this report, we have shown the next generation sequencing market by the platform.

Next Generation Sequencing Market Insight by Consumables

In this report, we have done a comprehensive analysis of the NGS market by consumables. There are various kinds of consumable used in next-generation sequencing like a sample, library preparation reagents, kits, automation devices, etc.

Next Generation Sequencing Informatics Market

NGS Informatics is one of the key growth factors that propel the overall NGS market to expand at a rapid pace. In this report, next-generation sequencing informatics market is divided into 6 parts; NGS Informatics Services, Primary and Secondary Data Analysis Tools, Storage, Computing, Biological Interpretation, and Reporting Tools and Laboratory Information Management System.

Company Analysis

All the companies have been analyzed from the following points: Overview, Recent Developments & Strategy.

  • Illumina
  • Thermo Fisher Scientific
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Roche

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Driver

4.1.1 Rapid Adoption of NGS in Clinical Application

4.1.2 Advancement in Next Generation Sequencing Platforms

4.1.3 Numerous Growth Factors for Next Generation Sequencing

4.2 Challenges

5. Global Next Generation Sequencing (NGS) Market

6. Market Share - Global Next Generation Sequencing (NGS)

6.1 By End-User

6.2 By Type of Test

6.3 By Disease

6.4 By NGS Informatics Type

7. End-User - Global Next Generation Sequencing Market

7.1 Academic Research

7.2 Healthcare

7.3 Biotech/Pharma

7.4 Government

7.5 Others

8. Type of Test - Global Clinical Next Generation Sequencing Market

8.1 Targeted Re-sequencing (TPS/WES)

8.2 RNA-Sequencing

8.3 Whole Genome Sequencing

8.4 ChIP-Sequencing

8.5 De Novo Sequencing

8.6 Methyl-Sequencing

9. Disease - Global Next Generation Sequencing Test Market

9.1 Reproductive Health

9.2 Rare Disease Diagnostics

9.3 Oncology (Cancer)

9.4 Metabolic Immune (Diagnostic)

9.5 Cardiovascular

9.6 Others

10. Platform - Global Next Generation Sequencing Market

11. Consumable - Global Next Generation Sequencing Market

12. Informatics - Global Next Generation Sequencing Market

12.1 NGS Informatics Services

12.2 Primary and Secondary Data Analysis Tools

12.3 Storage

12.4 Computing

12.5 Biological Interpretation and Reporting Tools

12.6 LIMS (Laboratory Information Management System)

13. Reimbursement

14. Company Analysis

14.1 Illumina

14.1.1 Overview

14.1.2 Recent Development and Strategy

14.2 Thermo Fisher Scientific

14.3 Pacific Biosciences

14.4 Oxford Nanopore Technologies

14.5 Roche

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Research and Markets

15 years ago we began selling market research reports. Today we are the world's largest market research store - connecting global information professionals with market insights and analysis from 1,700 research teams based across 81 countries.